Vaginal Health Test (Tiny Health)

Overview

The Tiny Health Vaginal Health Test utilises advanced metagenomic sequencing to provide a thorough examination of the vaginal microbiome, encompassing bacteria, fungi, viruses, and archaea. This approach allows for a detailed understanding of microbial community structures, including identification of the community state type (CST), which characterises the dominant microbial patterns present. The profile highlights the presence and relative levels of various microbial groups that can influence vaginal wellness, providing insights into the overall microbial balance and diversity.

This test offers valuable information for those interested in exploring their vaginal microbial environment in relation to general comfort and lifestyle. By assessing factors such as Lactobacillus abundance, microbial diversity, and the presence of different microbial communities, it contributes to a broader picture of vaginal health and resilience. The test results can support personal wellness goals by offering data that reflects the dynamic nature of the vaginal ecosystem without making medical or diagnostic interpretations.

Using high-depth sequencing techniques, the Tiny Health Vaginal Health Test delivers an extensive profile of microbial composition, enhancing understanding of vaginal microbiome stability and community patterns. This comprehensive microbial overview is designed to assist individuals in making informed choices related to their reproductive and vaginal health from a wellness perspective. It provides a scientific foundation for understanding how microbial ecosystems may relate to comfort and personal health optimisation.

Tiny Health Vaginal Health Test is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Tiny Health Vaginal Health Test is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.